Iron: An Underrated Factor in Aging

Key Takeaways

• Typical adult stores 3–5 g iron, mostly in hemoglobin and ferritin.
• Ferritin levels above 50 ng/mL linked to higher heart disease risk.
• Blood donation can cut heart attack risk up to 88 % in studies.
• Heme iron from animal foods raises ferritin more than plant iron.
• About half of U.S. adults have ferritin >75 ng/mL, raising disease risk.

Pulse Analysis

Iron is essential for oxygen transport and cellular metabolism, but the body’s iron balance is a double‑edged sword. Around 3–5 g of iron circulates in an adult, with most bound to hemoglobin and a significant portion stored as ferritin‑bound ferrihydrite, a hydrated iron oxyhydroxide. When excess iron encounters hydrogen peroxide—a by‑product of normal metabolism—it fuels the Fenton reaction, generating hydroxyl radicals that can damage DNA, lipids, and proteins. This oxidative cascade is a plausible mechanistic link between iron overload and the progression of neurodegenerative, cardiovascular, and oncologic diseases.

Epidemiological data increasingly tie higher serum ferritin, even within traditionally "normal" ranges, to adverse health outcomes. Large cohort studies have shown a graded rise in myocardial infarction and type‑2 diabetes risk as ferritin climbs above 50 ng/mL, with the strongest signals in populations consuming heme‑rich animal products. Notably, blood‑donation or therapeutic phlebotomy—simple methods to lower iron stores—have been associated with up to an 88 % reduction in heart‑attack incidence and a 60 % drop in cancer mortality, though healthy‑donor bias may temper these figures. Vegetarian and vegan groups consistently display lower ferritin levels and correspondingly better metabolic markers, underscoring the role of dietary iron source.

The implications for public health are substantial. If half of U.S. adults carry ferritin levels above 75 ng/mL, a sizable portion of the population could benefit from revised iron‑intake recommendations, targeted screening, and broader promotion of blood‑donation programs. Nutrition companies may pivot toward plant‑based iron supplements and fortified foods that avoid the rapid absorption of heme iron. Meanwhile, clinicians should consider ferritin as a dynamic risk marker rather than a static reference value, integrating iron‑reduction strategies into preventive care. Ongoing randomized trials will be critical to confirm causality and define safe lower thresholds for iron stores, paving the way for evidence‑based guidelines that balance iron’s vital functions against its oxidative hazards.